251 related articles for article (PubMed ID: 35846149)
21. Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma.
Li SR; Man QW; Liu B
Front Oncol; 2022; 12():943945. PubMed ID: 36452497
[TBL] [Abstract][Full Text] [Related]
22. Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma.
Jiang L; Yin X; Zhang H; Zhang X; Cao Z; Zhou M; Xu W
Biomed Res Int; 2023; 2023():4444869. PubMed ID: 36814797
[TBL] [Abstract][Full Text] [Related]
23. Cancer associated fibroblast derived gene signature determines cancer subtypes and prognostic model construction in head and neck squamous cell carcinomas.
Wu S; Huang C; Su L; Wong PP; Huang Y; Chen R; Lin P; Ye Y; Song P; Han P; Huang X
Cancer Med; 2023 Mar; 12(5):6388-6400. PubMed ID: 36404634
[TBL] [Abstract][Full Text] [Related]
24. A Signature of N
Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
Front Immunol; 2022; 13():809872. PubMed ID: 35185897
[TBL] [Abstract][Full Text] [Related]
25. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
[TBL] [Abstract][Full Text] [Related]
26. Development of a Prognostic Signature Based on Autophagy-related Genes for Head and Neck Squamous Cell Carcinoma.
Jin Y; Qin X
Arch Med Res; 2020 Nov; 51(8):860-867. PubMed ID: 32948377
[TBL] [Abstract][Full Text] [Related]
27. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
Li J; Tang LL; Ma J
BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
[TBL] [Abstract][Full Text] [Related]
28. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
29. Novel prognostic model established for patients with head and neck squamous cell carcinoma based on pyroptosis-related genes.
Shen Y; Li X; Wang D; Zhang L; Li X; Xia T; Shang X; Yang X; Su L; Fan X
Transl Oncol; 2021 Dec; 14(12):101233. PubMed ID: 34600420
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma.
Liu S; Liu W; Ding Z; Yang X; Jiang Y; Wu Y; Liu Y; Wu J
Front Mol Biosci; 2022; 9():912620. PubMed ID: 36339718
[No Abstract] [Full Text] [Related]
31. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival.
Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J
J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034
[TBL] [Abstract][Full Text] [Related]
32. Exploration of a predictive model based on genes associated with fatty acid metabolism and clinical treatment for head and neck squamous cell carcinoma.
Yuan Z; Huang J; Teh BM; Hu S; Hu Y; Shen Y
J Clin Lab Anal; 2022 Nov; 36(11):e24722. PubMed ID: 36181275
[TBL] [Abstract][Full Text] [Related]
33. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
Yue C; Ma H; Zhou Y
PeerJ; 2019; 7():e8128. PubMed ID: 31803536
[TBL] [Abstract][Full Text] [Related]
34. A Novel Pyroptosis-Related Gene Signature for Prognostic Prediction of Head and Neck Squamous Cell Carcinoma.
Qian X; Tang J; Chu Y; Chen Z; Chen L; Shen C; Li L
Int J Gen Med; 2021; 14():7669-7679. PubMed ID: 34764680
[TBL] [Abstract][Full Text] [Related]
35. Combination of Radiosensitivity Gene Signature and PD-L1 Status Predicts Clinical Outcome of Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study Based on The Cancer Genome Atlas Dataset.
Dai D; Guo Y; Shui Y; Li J; Jiang B; Wei Q
Front Mol Biosci; 2021; 8():775562. PubMed ID: 34970597
[No Abstract] [Full Text] [Related]
36. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
Yang C; Mei H; Peng L; Jiang F; Xie B; Li J
Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497
[TBL] [Abstract][Full Text] [Related]
37. Investigation of an FGFR-Signaling-Related Prognostic Model and Immune Landscape in Head and Neck Squamous Cell Carcinoma.
Chen Q; Chu L; Li X; Li H; Zhang Y; Cao Q; Zhuang Q
Front Cell Dev Biol; 2021; 9():801715. PubMed ID: 35237609
[No Abstract] [Full Text] [Related]
38. Comprehensive Analysis of the Roles and Prognostic Value of RNA-Binding Proteins in Head and Neck Squamous Cell Carcinoma.
Jin Y; Qin X
DNA Cell Biol; 2020 Oct; 39(10):1789-1798. PubMed ID: 32716650
[TBL] [Abstract][Full Text] [Related]
39. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma.
Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G
J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058
[TBL] [Abstract][Full Text] [Related]
40. Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma.
Fang J; Yang Z; Xie J; Li Z; Hu C; Yang M; Zhou X
Transl Oncol; 2021 Jul; 14(7):101094. PubMed ID: 33878525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]